Paloma Partners Management CO Vericel Corp Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $276,891 - $367,767	-18,546 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$15.01 - $18.89 $125,213 - $157,580	8,342 Added 81.75%	18,546 $350,000
Q1 2019 May 15, 2019	SELL	$16.23 - $20.29 $82,708 - $103,397	-5,096 Reduced 33.31%	10,204 $179,000
Q4 2018 Feb 14, 2019	BUY	$10.77 - $18.44 $164,781 - $282,132	15,300 New	15,300 $266,000

276

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.48B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.